KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Net Cash Flow (2019 - 2025)

Hims & Hers Health's Net Cash Flow history spans 7 years, with the latest figure at -$119.9 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 315.92% year-over-year to -$119.9 million; the TTM value through Dec 2025 reached $4.7 million, down 96.25%, while the annual FY2025 figure was $4.7 million, 96.25% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$119.9 million at Hims & Hers Health, up from -$777.7 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $849.0 million in Q2 2025 and bottomed at -$777.7 million in Q3 2025.
  • The 5-year median for Net Cash Flow is $7.8 million (2021), against an average of $9.9 million.
  • The largest YoY upside for Net Cash Flow was 3428.68% in 2025 against a maximum downside of 2258.26% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at $7.1 million in 2021, then plummeted by 258.31% to -$11.2 million in 2022, then skyrocketed by 446.44% to $38.7 million in 2023, then soared by 43.43% to $55.5 million in 2024, then tumbled by 315.92% to -$119.9 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Net Cash Flow are -$119.9 million (Q4 2025), -$777.7 million (Q3 2025), and $849.0 million (Q2 2025).